Between destiny and disease: Genetics and molecular pathways of human central nervous system aging

Progress in Neurobiology

Volumn 93, Issue 2, 2011, Pages 165-181

  Glorioso, Christin ^a   Sibille, Etienne ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Brain; Depression; Disease; Human; Neurodegenerative; Neuropsychiatric; Parkinson's disease; Postmortem; Schizophrenia; Sirtuin

Indexed keywords

AMPHETAMINE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; BROMOCRIPTINE; CATECHOL METHYLTRANSFERASE; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; KLOTHO PROTEIN; LEVODOPA; MITOCHONDRIAL DNA; NERVE GROWTH FACTOR; PRION PROTEIN; PROTEIN P53; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SIRTUIN 1; SIRTUIN 3; SIRTUIN 5; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

AGING; ALZHEIMER DISEASE; AUTOPSY; BIPOLAR DISORDER; BRAIN METABOLISM; CALORIC RESTRICTION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; DNA DAMAGE; DNA POLYMORPHISM; FERTILITY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; LONG TERM MEMORY; LONGEVITY; META ANALYSIS (TOPIC); METABOLIC REGULATION; MOTOR PERFORMANCE; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TISSUE MICROARRAY; WORKING MEMORY; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; NEUROLOGIC DISEASE; ONSET AGE; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGE OF ONSET; AGING; ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NERVOUS SYSTEM DISEASES; NEURONS; TRANSCRIPTION, GENETIC;

EID: 78650589676     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.11.006     Document Type: Review

References (148)

1. Alexopoulos G.S. Depression in the elderly. Lancet 2005, 365:1961-1970.
2. Alexopoulos G.S., Schultz S.K., Lebowitz B.D. Late-life depression: a model for medical classification. Biol. Psychiatry 2005, 58:283-289.
3. Anstey K., Christensen H. Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology 2000, 46:163-177.
4. Araki T., Sasaki Y., Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004, 305:1010-1013.
5. Arking D.E., Atzmon G., Arking A., Barzilai N., Dietz H.C. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ. Res. 2005, 96:412-418.
6. Arking D.E., Becker D.M., Yanek L.R., Fallin D., Judge D.P., Moy T.F., Becker L.C., Dietz H.C. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am. J. Hum. Genet. 2003, 72:1154-1161.
7. Arking D.E., Krebsova A., Macek M., Macek M., Arking A., Mian I.S., Fried L., Hamosh A., Dey S., McIntosh I., Dietz H.C. Association of human aging with a functional variant of klotho. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:856-861.
8. Avramopoulos D., Szymanski M., Wang R., Bassett S. Gene expression reveals overlap between normal aging and Alzheimer's disease genes. Neurobiol Aging. 2010.
9. Backman L., Ginovart N., Dixon R.A., Wahlin T.B., Wahlin A., Halldin C., Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am. J. Psychiatry 2000, 157:635-637.
10. Backman L., Nyberg L., Lindenberger U., Li S.C., Farde L. The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neurosci. Biobehav. Rev. 2006, 30:791-807.
11. Bartke A. Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging. Trends Endocrinol. Metab. 2006, 17:33-35.
12. Bauer J.H., Poon P.C., Glatt-Deeley H., Abrams J.M., Helfand S.L. Neuronal expression of p53 dominant-negative proteins in adult Drosophila melanogaster extends life span. Curr. Biol. 2005, 15:2063-2068.
13. Bellizzi D., Rose G., Cavalcante P., Covello G., Dato S., De Rango F., Greco V., Maggiolini M., Feraco E., Mari V., Franceschi C., Passarino G., De Benedictis G. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005, 85:258-263.
14. Berchtold N.C., Cribbs D.H., Coleman P.D., Rogers J., Head E., Kim R., Beach T., Miller C., Troncoso J., Trojanowski J.Q., Zielke H.R., Cotman C.W. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15605-15610.
15. Berr C., Richard F., Dufouil C., Amant C., Alperovitch A., Amouyel P. Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study. Neurology 1998, 51:734-737.
16. Bialecka M., Kurzawski M., Klodowska-Duda G., Opala G., Tan E.K., Drozdzik M. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Pharmacogenet. Genomics 2008, 18:815-821.
17. Bishop N.A., Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat. Rev. Genet. 2007, 8:835-844.
18. Bonafe M., Barbieri M., Marchegiani F., Olivieri F., Ragno E., Giampieri C., Mugianesi E., Centurelli M., Franceschi C., Paolisso G. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J. Clin. Endocrinol. Metab. 2003, 88:3299-3304.
19. Bonafe M., Olivieri F. Genetic polymorphism in long-lived people: cues for the presence of an insulin/IGF-pathway-dependent network affecting human longevity. Mol. Cell Endocrinol. 2009, 299:118-123.
20. Budovskaya Y.V., Wu K., Southworth L.K., Jiang M., Tedesco P., Johnson T.E., Kim S.K. An elt-3/elt-5/elt-6 GATA transcription circuit guides aging in C. elegans. Cell 2008, 134:291-303.
21. Buhot M.C., Wolff M., Benhassine N., Costet P., Hen R., Segu L. Spatial learning in the 5-HT1B receptor knockout mouse: selective facilitation/impairment depending on the cognitive demand. Learn. Mem. 2003, 10:466-477.
22. Calero M., Rostagno A., Matsubara E., Zlokovic B., Frangione B., Ghiso J. Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc. Res. Tech. 2000, 50:305-315.
23. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
24. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
25. Christensen H. What cognitive changes can be expected with normal ageing?. Aust. N. Z. J. Psychiatry 2001, 35:768-775.
26. Cohen E., Bieschke J., Perciavalle R.M., Kelly J.W., Dillin A. Opposing activities protect against age-onset proteotoxicity. Science 2006, 313:1604-1610.
27. Cohen E., Paulsson J.F., Blinder P., Burstyn-Cohen T., Du D., Estepa G., Adame A., Pham H.M., Holzenberger M., Kelly J.W., Masliah E., Dillin A. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 2009, 139:1157-1169.
28. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
29. Conde J.R., Streit W.J. Microglia in the aging brain. J. Neuropathol. Exp. Neurol. 2006, 65:199-203.
30. Cotzias G.C., Miller S.T., Nicholson A.R., Maston W.H., Tang L.C. Prolongation of the life-span in mice adapted to large amounts of L-dopa. Proc. Natl. Acad. Sci. U. S. A. 1974, 71:2466-2469.
31. Cotzias G.C., Miller S.T., Tang L.C., Papavasiliou P.S. Levodopa, fertility, and longevity. Science 1977, 196:549-551.
32. Daitoku H., Fukamizu A. FOXO transcription factors in the regulatory networks of longevity. J. Biochem. 2007, 141:769-774.
33. Dang W., Steffen K.K., Perry R., Dorsey J.A., Johnson F.B., Shilatifard A., Kaeberlein M., Kennedy B.K., Berger S.L. Histone H4 lysine 16 acetylation regulates cellular lifespan. Nature 2009, 459:802-807.
34. de Brabander J.M., Kramers R.J., Uylings H.B. Layer-specific dendritic regression of pyramidal cells with ageing in the human prefrontal cortex. Eur. J. Neurosci. 1998, 10:1261-1269.
35. de Frias C.M., Annerbrink K., Westberg L., Eriksson E., Adolfsson R., Nilsson L.G. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav. Genet. 2004, 34:533-539.
36. De Leo D., Padoani W., Scocco P., Lie D., Bille-Brahe U., Arensman E., Hjelmeland H., Crepet P., Haring C., Hawton K., Lonnqvist J., Michel K., Pommereau X., Querejeta I., Phillipe J., Salander-Renberg E., Schmidtke A., Fricke S., Weinacker B., Tamesvary B., Wasserman D., Faria S. Attempted and completed suicide in older subjects: results from the WHO/EURO Multicentre Study of Suicidal Behaviour. Int. J. Geriatr. Psychiatry 2001, 16:300-310.
37. De Luca M., Rose G., Bonafe M., Garasto S., Greco V., Weir B.S., Franceschi C., De Benedictis G. Sex-specific longevity associations defined by tyrosine hydroxylase-insulin-insulin growth factor 2 haplotypes on the 11p15.5 chromosomal region. Exp. Gerontol. 2001, 36:1663-1671.
38. Deary I.J., Gow A.J., Taylor M.D., Corley J., Brett C., Wilson V., Campbell H., Whalley L.J., Visscher P.M., Porteous D.J., Starr J.M. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 2007, 7:28.
39. Deary I.J., Harris S.E., Fox H.C., Hayward C., Wright A.F., Starr J.M., Whalley L.J. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neurosci. Lett. 2005, 378:22-27.
40. Deary I.J., Whiteman M.C., Pattie A., Starr J.M., Hayward C., Wright A.F., Carothers A., Whalley L.J. Cognitive change and the APOE epsilon 4 allele. Nature 2002, 418:932.
41. Deary I.J., Wright A.F., Harris S.E., Whalley L.J., Starr J.M. Searching for genetic influences on normal cognitive ageing. Trends Cogn. Sci. 2004, 8:178-184.
42. Diaz-Torga G., Feierstein C., Libertun C., Gelman D., Kelly M.A., Low M.J., Rubinstein M., Becu-Villalobos D. Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology 2002, 143:1270-1279.
43. Dickstein D.L., Kabaso D., Rocher A.B., Luebke J.I., Wearne S.L., Hof P.R. Changes in the structural complexity of the aged brain. Aging Cell 2007, 6:275-284.
44. Dranovsky A., Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry 2006, 59:1136-1143.
45. Droge W., Schipper H.M. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007, 6:361-370.
46. Duan H., Wearne S.L., Rocher A.B., Macedo A., Morrison J.H., Hof P.R. Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb. Cortex 2003, 13:950-961.
47. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
48. Era P., Jokela J., Heikkinen E. Reaction and movement times in men of different ages: a population study. Percept Motor Skills 1986, 63:111-130.
49. Erraji-Benchekroun L., Underwood M.D., Arango V., Galfalvy H., Pavlidis P., Smyrniotopoulos P., Mann J.J., Sibille E. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol. Psychiatry 2005, 57:549-558.
50. Feher A., Juhasz A., Rimanoczy A., Kalman J., Janka Z. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer Dis. Assoc. Disord. 2009, 23:224-228.
51. Fillit H.M., Butler R.N., O'Connell A.W., Albert M.S., Birren J.E., Cotman C.W., Greenough W.T., Gold P.E., Kramer A.F., Kuller L.H., Perls T.T., Sahagan B.G., Tully T. Achieving and maintaining cognitive vitality with aging. Mayo Clin. Proc. 2002, 77:681-696.
52. Finch C.E. Neurons, glia, and plasticity in normal brain aging. Neurobiol Aging 2003, 24(Suppl 1):S123-S127. (discussion S131).
53. Finkel T., Deng C.X., Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591.
54. Fiske A., Wetherell J.L., Gatz M. Depression in older adults. Annu. Rev. Clin. Psychol. 2009, 5:363-389.
55. Flachsbart F., Caliebe A., Kleindorp R., Blanche H., von Eller-Eberstein H., Nikolaus S., Schreiber, S, Nebel A. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2700-2705.
56. Fozard J.L., Vercryssen M., Reynolds S.L., Hancock P.A., Quilter R.E. Age differences and changes in reaction time: the Baltimore Longitudinal Study of Aging. J. Gerontol. 1994, 49:P179-189.
57. Gan L., Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008, 58:10-14.
58. Gianaros P.J., Greer P.J., Ryan C.M., Jennings J.R. Higher blood pressure predicts lower regional grey matter volume: consequences on short-term information processing. Neuroimage 2006, 31:754-765.
59. Glorioso C., Sabatini M., Unger T., Hashimoto T., Monteggia L.M., Lewis D.A., Mirnics K. Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol. Psychiatry 2006, 11:633-648.
60. Glorioso, C.A., Oh, S., Sibille, E., 2010. Brain molecular aging, promotion of neurological disease and modulation by sirtuin5 longevity gene polymorphism. Neurobiol Dis, [Epub ahead of print].
61. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 1997, 41:17-24.
62. Gondo Y., Hirose N., Arai Y., Yamamura K., Shimizu K., Takayama M., Ebihara Y., Nakazawa S., Inagaki H., Masui Y., Kitagawa K. Contribution of an affect-associated gene to human longevity: prevalence of the long-allele genotype of the serotonin transporter-linked gene in Japanese centenarians. Mech. Ageing Dev. 2005, 126:1178-1184.
63. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
64. Harris S.E., Fox H., Wright A.F., Hayward C., Starr J.M., Whalley L.J., Deary I.J. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol. Psychiatry 2006, 11:505-513.
65. Hasin D.S., Goodwin R.D., Stinson F.S., Grant B.F. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch. Gen. Psychiatry 2005, 62:1097-1106.
66. Haug H., Kuhl S., Mecke E., Sass N.L., Wasner K. The significance of morphometric procedures in the investigation of age changes in cytoarchitectonic structures of human brain. J. Hirnforsch. 1984, 25:353-374.
67. Hawton K, van Heeringen K. Suicide. Lancet 2009, 373:1372-1381.
68. Houlihan L.M., Harris S.E., Luciano M., Gow A.J., Starr J.M., Visscher P.M., Deary I.J. Replication study of candidate genes for cognitive abilities: the Lothian Birth Cohort 1936. Genes Brain Behav. 2009, 8:238-247.
69. Imamura A., Okumura K., Ogawa Y., Murakami R., Torigoe M., Numaguchi Y., Murohara T. Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese. Clin Chim Acta 2006, 371(102):66-70.
70. Joseph J., Cole G., Head E., Ingram D. Nutrition, brain aging, and neurodegeneration. J. Neurosci. 2009, 29:12795-12801.
71. Kachiwala S.J., Harris S.E., Wright A.F., Hayward C., Starr J.M., Whalley L.J., Deary I.J. Genetic influences on oxidative stress and their association with normal cognitive ageing. Neurosci. Lett. 2005, 386:116-120.
72. Kaufman A.S. Assessing Adolescent and Adult Intelligence 1990, Allyn & Bacon, Boston.
73. Kauranen K., Vanharanta H. Influences of aging, gender, and handedness on motor performance of upper and lower extremities. Percept Motor Skills 1996, 82:515-525.
74. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., McCord R.A., Ongaigui K.C., Boxer L.D., Chang H.Y., Chua K.F. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136:62-74.
75. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 2005, 120:449-460.
76. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
77. Kuningas M., Putters M., Westendorp R.G., Slagboom P.E, van Heemst D. SIRT1 gene age-related diseases, and mortality: the Leiden 85-plus study. J. Gerontol. A: Biol. Sci. Med. Sci. 2007, 62:960-965.
78. Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., Ohyama Y., Kurabayashi M., Kaname T., Kume E., Iwasaki H., Iida A., Shiraki-Iida T., Nishikawa S., Nagai R., Nabeshima Y.I. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390:45-51.
79. Kurosu H., Yamamoto M., Clark J.D., Pastor J.V., Nandi A., Gurnani P., McGuinness O.P., Chikuda H., Yamaguchi M., Kawaguchi H., Shimomura I., Takayama Y., Herz J., Kahn C.R., Rosenblatt K.P., Kuro-o M. Suppression of aging in mice by the hormone Klotho. Science 2005, 309:1829-1833.
80. Libert S., Cohen D., Guarente L. Neurogenesis directed by Sirt1. Nat. Cell Biol. 2008, 10:373-374.
81. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
82. Luo Y., Roth G.S. The roles of dopamine oxidative stress and dopamine receptor signaling in aging and age-related neurodegeneration. Antioxid. Redox Signal 2000, 2:449-460.
83. Masuda H., Chikuda H., Suga T., Kawaguchi H., Kuro-o M. Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech. Ageing Dev. 2005, 126:1274-1283.
84. Maswood N., Young J., Tilmont E., Zhang Z., Gash D.M., Gerhardt G.A., Grondin R., Roth G.S., Mattison J., Lane M.A., Carson R.E., Cohen R.M., Mouton P.R., Quigley C., Mattson M.P., Ingram D.K. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18171-18176.
85. Mather M., Carstensen L.L. Aging and motivated cognition: the positivity effect in attention and memory. Trends Cogn. Sci. 2005, 9:496-502.
86. Mattay V.S., Goldberg T.E., Sambataro F., Weinberger D.R. Neurobiology of cognitive aging: insights from imaging genetics. Biol. Psychol. 2008, 79:9-22.
87. Mattson M.P. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann. N. Y. Acad. Sci. 2008, 1144:97-112.
88. Mattson M.P., Maudsley S., Martin B. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res. Rev. 2004, 3:445-464.
89. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004, 27:589-594.
90. Miller J.A., Oldham M.C., Geschwind D.H. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J. Neurosci. 2008, 28:1410-1420.
91. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain. Science 1997, 278:412-419.
92. Murakami H., Bessinger K., Hellmann J., Murakami S. Manipulation of serotonin signal suppresses early phase of behavioral aging in Caenorhabditis elegans. Neurobiol. Aging 2008, 29:1093-1100.
93. Muscari A., Giannoni C., Pierpaoli L., Berzigotti A., Maietta P., Foschi E., Ravaioli C., Poggiopollini G., Bianchi G., Magalotti D., Tentoni C., Zoli M. Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. Int. J. Geriatr. Psychiatry 2009, 25(10):1055-1064.
94. Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., Wang L., Blesch A., Kim A., Conner J.M., Rockenstein E., Chao M.V., Koo E.H., Geschwind D., Masliah E., Chiba A.A., Tuszynski M.H. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 2009, 15:331-337.
95. Narasimhan S.D., Yen K., Tissenbaum H.A. Converging pathways in lifespan regulation. Curr. Biol. 2009, 19:R657-666.
96. Nemoto K., Ohnishi T., Mori T., Moriguchi Y., Hashimoto R., Asada T., Kunugi H. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci. Lett. 2006, 397:25-29.
97. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Ohta K., Kinouchi S., Shibuya-Tayoshi S., Tayoshi S., Aono M., Kameoka N., Sumitani S., Tomotake M., Kaneda Y., Taniguchi T., Ishimoto Y., Ohmori T. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci. Lett. 2006, 401:1-5.
98. Nussbaum R.L., Ellis C.E. Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 2003, 348:1356-1364.
99. O'Hara R., Schroder C.M., Mahadevan R., Schatzberg A.F., Lindley S., Fox S., Weiner M., Kraemer H.C., Noda A., Lin X., Gray H.L., Hallmayer J.F. Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol. Psychiatry 2007, 12:544-555.
100. Ogata N., Matsumura Y., Shiraki M., Kawano K., Koshizuka Y., Hosoi T., Nakamura K., Kuro O.M., Kawaguchi H. Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone 2002, 31:37-42.
101. Panza F., Solfrizzi V., Colacicco A.M., D'Introno A., Capurso C., Torres F., Del Parigi A., Capurso S., Capurso A. Mediterranean diet and cognitive decline. Public Health Nutr. 2004, 7:959-963.
102. Papaconstantinou J. Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Mol. Cell Endocrinol. 2009, 299:89-100.
103. Park D.C., Lautenschlager G., Hedden T., Davidson N.S., Smith A.D., Smith P.K. Models of visuospatial and verbal memory across the adult life span. Psychol. Aging 2002, 17:299-320.
104. Park D.C., Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu. Rev. Psychol. 2009, 60:173-196.
105. Pawlikowska L., Hu D., Huntsman S., Sung A., Chu C., Chen J., Joyner A.H., Schork N.J., Hsueh W.C., Reiner A.P., Psaty B.M., Atzmon G., Barzilai N., Cummings S.R., Browner W.S., Kwok P.Y., Ziv E. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 2009, 8:460-472.
106. Payton A., Gibbons L., Davidson Y., Ollier W., Rabbitt P., Worthington J., Pickles A., Pendleton N., Horan M. Influence of serotonin transporter gene polymorphisms on cognitive decline and cognitive abilities in a nondemented elderly population. Mol. Psychiatry 2005, 10:1133-1139.
107. Peters A., Sethares C., Luebke J.I. Synapses are lost during aging in the primate prefrontal cortex. Neuroscience 2008, 152:970-981.
108. Peters A., Sethares C., Moss M.B. The effects of aging on layer 1 in area 46 of prefrontal cortex in the rhesus monkey. Cereb. Cortex 1998, 8:671-684.
109. Petrascheck M., Ye X., Buck L.B. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 2007, 450:553-556.
110. Petrascheck M., Ye X., Buck L.B. A high-throughput screen for chemicals that increase the lifespan of Caenorhabditis elegans. Ann. N. Y. Acad. Sci. 2009, 1170:698-701.
111. Qin W., Chachich M., Lane M., Roth G., Bryant M., de Cabo R., Ottinger M., Mattison A.J., Ingram D., Gandy S., Pasinetti G.M. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J. Alzheimers Dis. 2006, 10:417-422.
112. Resnick S.M., Pham D.L., Kraut M.A., Zonderman A.B., Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci. 2003, 23:3295-3301.
113. Rex C.S., Lauterborn J.C., Lin C.Y., Kramar E.A., Rogers G.A., Gall C.M., Lynch G. Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J. Neurophysiol. 2006, 96:677-685.
114. Reynolds C.A., Jansson M., Gatz M., Pedersen N.L. Longitudinal change in memory performance associated with HTR2A polymorphism. Neurobiol. Aging 2006, 27:150-154.
115. Rollo C.D. Dopamine and aging: intersecting facets. Neurochem. Res. 2009, 34:601-629.
116. Rose G., Dato S., Altomare K., Bellizzi D., Garasto S., Greco V., Passarino G., Feraco E., Mari V., Barbi C., BonaFe M., Franceschi C., Tan Q., Boiko S., Yashin A.I., De Benedictis G. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 2003, 38:1065-1070.
117. Rowe J.B., Hughes L., Williams-Gray C.H., Bishop S., Fallon S., Barker R.A., Owen A.M. The val(158)met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease. Neurobiol. Aging 2008, 31(6):1064-1068.
118. Ruffman T., Henry J.D., Livingstone V., Phillips L.H. A meta-analytic review of emotion recognition and aging: implications for neuropsychological models of aging. Neurosci. Biobehav. Rev. 2008, 32:863-881.
119. Rujescu D., Hartmann A.M., Gonnermann C., Moller H.J., Giegling I. M129V variation in the prion protein may influence cognitive performance. Mol. Psychiatry 2003, 8:937-941.
120. Salthouse T.A. Adult Cognition 1982, Springer-Verlag, New York.
121. Salthouse T.A. Mechanisms of Age-cognition Relations in Adulthood 1996, Lawrence Earlbaum Associates, Hillsdale, NJ.
122. Schaie K.W. Intellectual Development in Adulthood 1996, Cambridge University Press, Cambridge.
123. Scheibel M.E., Lindsay R.D., Tomiyasu U., Scheibel A.B. Progressive dendritic changes in aging human cortex. Exp. Neurol. 1975, 47:392-403.
124. Seshadri S., Wolf P.A., Beiser A., Elias M.F., Au R., Kase C.S., D'Agostino R.B., DeCarli C. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology 2004, 63:1591-1599.
125. Sibille E., Su J., Leman S., Le Guisquet A.M., Ibarguen-Vargas Y., Joeyen-Waldorf J., Glorioso C., Tseng G.C., Pezzone M., Hen R., Belzung C. Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity. Mol. Psychiatry. 2007, 12:1042-1056. 1975.
126. Simunovic F., Yi M., Wang Y., Macey L., Brown L.T., Krichevsky A.M., Andersen S.L., Stephens R.M., Benes F.M., Sonntag K.C. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain 2009, 132:1795-1809.
127. Smith C.D., Chebrolu H., Wekstein D.R., Schmitt F.A., Markesbery W.R. Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol. Aging 2007, 28:1075-1087.
128. Smith J.D. Apolipoproteins and aging: emerging mechanisms. Ageing Res. Rev. 2002, 1:345-365.
129. Starr J.M., Fox H., Harris S.E., Deary I.J., Whalley L.J. COMT genotype and cognitive ability: a longitudinal aging study. Neurosci. Lett. 2007, 421:57-61.
130. Sublette M.E., Baca-Garcia E., Parsey R.V., Oquendo M.A., Rodrigues S.M., Galfalvy H., Huang Y.Y., Arango V., Mann J.J. Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1652-1655.
131. Sze J.Y., Victor M., Loer C., Shi Y., Ruvkun G. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 2000, 403:560-564.
132. Tanner C.M., Goldman S.M. Epidemiology of Parkinson's disease. Neurol. Clin. 1996, 14:317-335.
133. Tapia-Arancibia L., Aliaga E., Silhol M., Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev. 2008, 59:201-220.
134. Thomson P.A., Harris S.E., Starr J.M., Whalley L.J., Porteous D.J., Deary I.J. Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci. Lett. 2005, 389:41-45.
135. Tisserand D.J., Pruessner J.C., Sanz Arigita E.J., van Boxtel M.P., Evans A.C., Jolles A.C., Uylings H.B. Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry. Neuroimage 2002, 17:657-669.
136. Tisserand D.J., van Boxtel M.P., Pruessner J.C., Hofman P., Evans A.C., Jolles J. A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. Cereb. Cortex 2004, 14:966-973.
137. Tsuang M.T., Tohen M. Textbook in Psychiatric Epidemiology 2002, Wiley, Weinheim, Germany.
138. Uchida A., Komiya Y., Tashiro T., Yorifuji H., Kishimoto T., Nabeshima Y., Hisanaga S. Neurofilaments of Klotho, the mutant mouse prematurely displaying symptoms resembling human aging. J. Neurosci. Res. 2001, 64:364-370.
139. Unger J.W. Glial reaction in aging and Alzheimer's disease. Microsc. Res. Tech. 1998, 43:24-28.
140. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., Nelson L.M. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 2003, 157:1015-1022.
141. Volkow N.D., Gur R.C., Wang G.J., Fowler J.S., Moberg P.J., Ding Y.S., Hitzemann R., Smith G., Logan J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am. J. Psychiatry 1998, 155:344-349.
142. Volkow N.D., Logan J., Fowler J.S., Wang G.J., Gur R.C., Wong C., Felder C., Gatley S.J., Ding Y.S., Hitzemann R., Pappas N. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am. J. Psychiatry 2000, 157:75-80.
143. Wechsler D. Manual for the Weschler Adult Intelligence Scale-Revised 1981, The Psychological Corporation, New York.
144. Wilson R.S., Beckett L.A., Barnes L.L., Schneider J.A., Bach J., Evans D.A., Bennett D.A. Individual differences in rates of change in cognitive abilities of older persons. Psychol. Aging 2002, 17:179-193.
145. Witte A.V., Fobker M., Gellner R., Knecht S., Floel A. Caloric restriction improves memory in elderly humans. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1255-1260.
146. Wolff M., Benhassine N., Costet P., Hen R., Segu L., Buhot M.C. Delay-dependent working memory impairment in young-adult and aged 5-HT1BKO mice as assessed in a radial-arm water maze. Learn. Mem. 2003, 10:401-409.
147. Yankner B.A., Lu T., Loerch P. The aging brain. Annu. Rev. Pathol. 2008, 3:41-66.
148. Zhao Y., Sun H., Lu J., Li X., Chen X., Tao D., Huang W., Huang B. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. J. Exp. Biol. 2005, 208:697-705.